Enlaza Therapeutics, a venture-backed La Jolla biotech with a Vertex Pharmaceuticals collaboration potentially worth more than $2 billion, renewed 37,013 square feet of...
ByThe RegistryNovember 14, 2026 
Signup for news and special announcements!
You have successfully joined our subscriber list.
Error: Contact form not found.